Infections in Simultaneous Pancreas/Kidney Transplant (SPKT) Recipients
1Georgetown University School of Medicine, Washington, DC, 2Division of Infectious Diseases and Travel Medicine, Medstar Georgetown University Hospital, Washington, DC, 3Medstar Georgetown Transplant Institute, Medstar Georgetown University Hospital, Washington, DC
Meeting: 2020 American Transplant Congress
Abstract number: A-255
Keywords: Infection, Kidney/pancreas transplantation, Outcome
Session Information
Session Name: Poster Session A: Pancreas and Islet: All Topics
Session Type: Poster Session
Date: Saturday, May 30, 2020
Session Time: 3:15pm-4:00pm
Presentation Time: 3:30pm-4:00pm
Location: Virtual
*Purpose: Simultaneous pancreas/kidney transplant (SPKT) is indicated for diabetic patients (pts) with chronic kidney disease and represents the largest proportion of pancreas transplants performed. Infection is a common complication post SPKT; however, etiologies and risk factors need further characterization.
*Methods: We performed a retrospective chart review of all pts who underwent an SPKT from 2015 – 2018 at our center. Pts demographics/outcomes, infection episodes, rejection episodes, and post-operative complications were collected for up to 180 days post SPKT. Fisher’s Exact test, Student’s T-Test and descriptive statistics were used.
*Results: 71 pts underwent SPKT during the observation period with the following characteristics: 58% male, mean age 43.5 years, mean length of stay (LOS) 8.5 days post SPKT, rate of return to OR in 30 days 16.9% (12/71), rejection rate of 25.4% (18/71), and mean readmission rate within 90 days 57.7% (41/71). 84.5% (60/71) of pts developed a total of 143 infection episodes within 180 days post SPKT and 65% (39/60) of those pts developed >1 infection episode. The mean time to onset of first infection was 55.3 days, with a median of 27.5 days for bacterial, 51 days for fungal, and 90 days for viral infection. The most common laboratory confirmed infections were as follows: 46.7% (28/60) bacterial, 11.7% (8/60) fungal, and 65.0% (39/60) viral. The most common sites of laboratory confirmed bacterial infections were urine (47.3%), blood stream (23.6%), and surgical site/organ space (14.6%). 12.7% (9/71) developed MDR infections (5.6% {4/71} with C. difficile). The most common fungus isolated was candida species; there was one episode of cryptococcal meningitis and one episode of invasive pulmonary aspergillosis identified. CMV infection occurred in 35.2% (25/71) of pts with a mean time from SPKT to CMV infection of 122 days. BKV viruria/viremia occurred in 36.6% (26/71) of pts with a mean time of 41 days post SPKT; 69.2% (18/26) of these pts had a reduction in immunosuppression. For patients with infections vs those without infection, there were no statistical differences with the following comparisons: kidney rejection (8% vs. 0%; p=1), dialysis post-transplant (12% vs 0%; p=0.59), pancreas rejection (18.3% vs 27.3% p=0.41), readmission within 90 days from initial transplant (62% vs 36%; p=0.184), return to OR within 30 days (18% vs 9%; p=0.68), or LOS after SPKT (8.5 vs 8.3 days; p=0.81). During 6 months of followup, overall patient survival was 97.2%; infection contributed to the cause of death in 2 pts.
*Conclusions: High rates of infection occur in SPKT recipients during the 6 month post transplant period, but despite this patient outcomes were favorable.
To cite this abstract in AMA style:
O'Neill JW, Copeland MJ, Schrank SD, Cooper M, Abrams P, Javaid B, Timpone JG. Infections in Simultaneous Pancreas/Kidney Transplant (SPKT) Recipients [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/infections-in-simultaneous-pancreas-kidney-transplant-spkt-recipients/. Accessed November 22, 2024.« Back to 2020 American Transplant Congress